Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2009 | 1 |
2013 | 1 |
2020 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Cost-Effectiveness Analysis of Patiromer in Combination with Renin-Angiotensin-Aldosterone System Inhibitors for Chronic Kidney Disease in Sweden.
Pharmacoeconomics. 2020 Jul;38(7):747-764. doi: 10.1007/s40273-020-00902-w.
Pharmacoeconomics. 2020.
PMID: 32239480
Cost per patient and potential budget implications of denosumab compared with zoledronic acid in adults with bone metastases from solid tumours who are at risk of skeletal-related events: an analysis for Austria, Sweden and Switzerland.
Lothgren M, Ribnicsek E, Schmidt L, Habacher W, Lundkvist J, Pfeil AM, Biteeva I, Vrouchou P, Bracco A.
Lothgren M, et al. Among authors: vrouchou p.
Eur J Hosp Pharm. 2013 Aug;20(4):227-231. doi: 10.1136/ejhpharm-2012-000235. Epub 2013 Feb 21.
Eur J Hosp Pharm. 2013.
PMID: 23888248
Free PMC article.
Item in Clipboard
Pemetrexed approved for the first-line treatment of non-small-cell lung cancer: summary of the NICE appraisal.
Vrouchou P, Kandaswamy P, George E, Barnett D.
Vrouchou P, et al.
Lancet Oncol. 2009 Nov;10(11):1031-2. doi: 10.1016/s1470-2045(09)70289-x.
Lancet Oncol. 2009.
PMID: 19891055
No abstract available.
Item in Clipboard
Cite
Cite